We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.71B
AUM Growth
+$182M
Cap. Flow
-$102M
Cap. Flow %
-1.32%
Top 10 Hldgs %
27.14%
Holding
420
New
12
Increased
175
Reduced
164
Closed
17

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$73.9M
2
MDT icon
Medtronic
MDT
+$52.6M
3
TFC icon
Truist Financial
TFC
+$30.9M
4
JNJ icon
Johnson & Johnson
JNJ
+$11.1M
5
HON icon
Honeywell
HON
+$10.3M

Top Sells

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$66.7M
2
SJM icon
J.M. Smucker
SJM
+$57.4M
3
KMB icon
Kimberly-Clark
KMB
+$35.4M
4
NVS icon
Novartis
NVS
+$19.8M
5
WEC icon
WEC Energy
WEC
+$5.61M

Sector Composition

Rank Sector Weight
1 Consumer Staples 16.9%
2 Healthcare 15.69%
3 Technology 15.19%
4 Financials 12.45%
5 Industrials 12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BF.B icon
201
Brown-Forman Class B
BF.B
$13.2B
$1.29M 0.02%
40,513
-312
-0.8% -$9.65K
REIS
202
DELISTED
Reis, Inc.
REIS
$1.24M 0.02%
49,910
+3,580
+8% +$86.2K
JJSF icon
203
J&J Snack Foods
JJSF
$1.43B
$1.22M 0.02%
10,235
+705
+7% +$74.7K
VWO icon
204
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$1.22M 0.02%
34,502
-8,174
-19% -$279K
NVEC icon
205
NVE Corp
NVEC
$562M
$1.21M 0.02%
20,706
+230
+1% +$13.1K
COR icon
206
Cencora
COR
$60.6B
$1.2M 0.02%
15,135
-22,745
-60% -$1.82M
OZK icon
207
Bank OZK
OZK
$5.6B
$1.2M 0.02%
32,012
+780
+2% +$30.7K
VOD icon
208
Vodafone
VOD
$36.3B
$1.2M 0.02%
38,882
-709
-2% -$23K
OMCL icon
209
Omnicell
OMCL
$1.61B
$1.18M 0.02%
34,610
+2,510
+8% +$78.3K
IWM icon
210
iShares Russell 2000 ETF
IWM
$79.8B
$1.18M 0.02%
10,224
+15
+0.1% +$1.69K
DGX icon
211
Quest Diagnostics
DGX
$25.7B
$1.17M 0.02%
14,375
+1,163
+9% +$88.6K
SMG icon
212
ScottsMiracle-Gro
SMG
$3.82B
$1.15M 0.01%
16,485
+1,200
+8% +$83.4K
SAIC icon
213
Saic
SAIC
$4.95B
$1.12M 0.01%
19,198
+1,553
+9% +$84.4K
TRV icon
214
Travelers Companies
TRV
$78.1B
$1.11M 0.01%
9,315
+15
+0.2% +$1.7K
DHR icon
215
Danaher
DHR
$137B
$1.1M 0.01%
16,149
ESRX
216
DELISTED
Express Scripts Holding Company
ESRX
$1.08M 0.01%
14,311
-35
-0.2% -$2.57K
BAX icon
217
Baxter International
BAX
$13.5B
$1.08M 0.01%
23,886
-620
-3% -$27.2K
OKS
218
DELISTED
Oneok Partners LP
OKS
$1.08M 0.01%
26,880
DD
219
DELISTED
Du Pont De Nemours E I
DD
$1.04M 0.01%
16,020
-1,785
-10% -$117K
ABAX
220
DELISTED
Abaxis Inc
ABAX
$1.04M 0.01%
21,953
+1,565
+8% +$70.8K
MNRO icon
221
Monro
MNRO
$383M
$1.03M 0.01%
16,245
+1,160
+8% +$76.7K
ZTS icon
222
Zoetis
ZTS
$32.4B
$1.02M 0.01%
21,459
-896
-4% -$42.3K
FLXS icon
223
Flexsteel Industries
FLXS
$302M
$1M 0.01%
25,330
+1,750
+7% +$72.2K
VMI icon
224
Valmont Industries
VMI
$9.3B
$1M 0.01%
7,393
+550
+8% +$72.7K
NS
225
DELISTED
NuStar Energy L.P.
NS
$994K 0.01%
19,954

Similar funds

Bahl & Gaynor's Q2 2016 Portfolio in Review

As of Q2 2016, Bahl & Gaynor held 420 positions worth $7.71B, up 2.4% from $7.53B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q2 2016 filing shows 12 new, 175 increased, 164 reduced and 17 closed positions. Its largest new stake was Simpson Manufacturing: 23,694 shares worth $947K. The largest sale was Analog Devices, an estimated $66.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Bahl & Gaynor's largest Q2 2016 buy was Simpson Manufacturing: 23,694 shares worth $947K.
  • Bahl & Gaynor added most to Texas Instruments in Q2 2016, an estimated $73.9M increase.
  • Bahl & Gaynor's biggest Q2 2016 reduction was Analog Devices, cutting an estimated $66.7M.
  • Bahl & Gaynor fully exited Airgas Inc in Q2 2016, selling an estimated $3.17M.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $7.71B portfolio in Q2 2016.
  • Bahl & Gaynor opened 12 new positions and closed 17 in Q2 2016.
  • Bahl & Gaynor's portfolio value rose 2.4% quarter-over-quarter to $7.71B.

Based on Bahl & Gaynor's 13F filing for Q2 2016, filed 10 Aug 2016.